Stimulation of gap junctional intercellular communication by thalidomide and thalidomide analogs in human skin fibroblasts

Biochemical Pharmacology

Volumn 53, Issue 10, 1997, Pages 1553-1557

  Nicolai, Swantje ^a   Sies, Helmut ^a   Stahl, Wilhelm ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cell culture; Dye transfer; Gap junctions; Intercellular communication; Teratogen; Thalidomide

Indexed keywords

2 (2,6 DIOXO 3 PIPERIDINYL)PHTHALIMIDINE; 2 PHTHALIMIDO GLUTARIC ACID; RETINOIC ACID; SUPIDIMIDE; TERATOGENIC AGENT; THALIDOMIDE; THALIDOMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL COMMUNICATION; CELL JUNCTION; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; DRUG DNA INTERACTION; DRUG STRUCTURE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; LEPROSY; LIVER MICROSOME; PRIORITY JOURNAL; SKIN FIBROBLAST; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY;

CELL COMMUNICATION; CELL LINE; FIBROBLASTS; GAP JUNCTIONS; HUMANS; SKIN; STEREOISOMERISM; THALIDOMIDE;

EID: 0030842120     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00096-8     Document Type: Article

References (27)

1. Lenz W, A short history of thalidomide embryopathy. Teratology 38: 203-215, 1988.
2. Stephens TD, Proposed mechanisms of action in thalidomide embryopathy. Teratology 38: 229-239, 1988.
3. Neubert R, Hinz N, Thiel R and Neubert D, Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide. Life Sci 58: 295-316, 1996.
4. Sheskin J, Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6: 303-306, 1965.
5. Crawford CL, Use of thalidomide in leprosy. Adv Drug React Toxicol Rev 13: 177-192, 1994.
6. Field EO, Gibbs JE, Tucker DF and Hellmann K, Effect of thalidomide on the graft versus host reaction. Nature 211: 1308-1310, 1966.
7. Uthoff K, Zehr KJ, Gaudin PB, Kumar P, Cho PW, Vogelsang G, Hruban RH, Baumgartner WA and Stuart RS, Thalidomide as replacement for steroids in immunosuppression after lung transplantation. Ann Thorac Surg 59: 277-282, 1995.
8. D'Amato RJ, Loughnan MS, Flynn E and Folkman J, Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci 91: 4082-4085, 1994.
9. Makonakawkyoon S, Limson-Pobre RNR, Moreira AL and Schauf V, Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci 90: 5974-5978, 1993.
10. Nogueira AC, Neubert R, Helge H, and Neubert D, Thalidomide and the immune system. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells. Life Sci 55: 77-92, 1994.
11. Geitz H., Handt S, and Zwingenberger K, Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacol 31: 213-221, 1996.
12. Mchugh SM, Rifkin IR, Deighton J, Wilson AB, Lachman PJ, Lockwood CM and Ewan PW, The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 99: 160-167, 1995.
13. Moreira A, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA and Kaplan G, Thalidomide exerts its inhibitory action on tumor necrosis factor a by enhancing mRNA degradation. J Exp Med 177: 1675-1680, 1993.
14. Goodenough DA, Goliger JA, and Paul DL, Connexins, connexons, and intercellular communication. Annu Rev Biochem 65: 475-502, 1996.
15. Dahl E, Winterhager E, Traub O and Willecke K, Expression of gap junction genes, connexin40 and connexin43, during fetal mouse development. Anat Embryol 191: 267-278, 1995.
16. Damen P, Dictus WJAG, Role of gap junctions in mesoderm induction in Patella vulgata (Mollusca, Gastropoda): A reinvestigation. Progr Cell Res 3: 219-223, 1993.
17. Loch-Caruso R and Trosko JE, Inhibited intercellular communication as a mechanistic link between teratogenesis and carcinogenesis. CRC Crit Rev Toxicol 16: 157-183, 1985.
18. Mehta PP, Bertram JS and Loewenstein WR, The actions of retinoids on cellular growth correlate with their actions on gap junctional communication. J Cell Biol 108: 1053-1065, 1989.
19. Hanusch M, Stahl W, Schulz WA and Sies H, Induction of gap junctional communication by 4-oxoretinoic acid generated from its precursor canthaxanthin. Arch Biochem Biophys 317: 423-428, 1995.
20. Stahl W, Nicolai S, Hanusch M and Sies H, Vitamin D influences gap junctional communication in C3H/10T1/2 murine fibroblast cells. FEBS Lett 352: 1-3, 1994.
21. Clairmont A, Tessmann D, Stock A, Nicolai S, Stahl W and Sies H, Induction of gap junctional communication by vitamin D in human skin fibroblasts is dependent on the nuclear vitamin D receptor. Carcinogenesis 17: 1389-1391, 1996.
22. Budunova IV and Williams GM, Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity base on the modulation of intercellular communication. Cell Biol Toxicol 10: 71-116, 1994.
23. Cadenas E, and Sies H, Low level chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide. Eur J Biochem 124: 349-356, 1982.
24. Steward WW, Functional connections between cells as revealed by dye-coupling with a fluorescent naphthalimide tracer. Cell 14: 741-759, 1978.
25. Trosko JE, Yotti LP, Warren ST, Tsushimoto G, and Chang C, Inhibition of cell-cell communication by tumor promotors. In: Cocarcinogenesis and Biological Effects of Tumor Promotors (Eds. Hecker E, Kunz W, Fusenig NE, Marks F, and Thielmann HW) pp. 565-585, Raven Press, NY, 1982.
26. Braun AG, and Weinreb, SL, Teratogen metabolism: spontaneous decay products of thalidomide analogues are not bioactivated by liver microsomes. Teratogenesis Carcinogenesis and Mutagenesis 5: 149-158, 1985.
27. Atra E, and Sato El, Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide. Clin Exper Rheumatol 11: 487-493, 1993.